Close
NOTICE: StreetInsider.com will be undergoing maintenance on Saturday, June 8th, from 11 AM to 10 PM EDT, and will be temporarily inaccessible.
Jun 3, 2024 07:31AM
May 31, 2024 02:00PM
May 31, 2024 11:00AM
May 30, 2024 04:00PM
May 30, 2024 02:46PM
May 30, 2024 02:44PM
May 30, 2024 07:30AM Xeris Pharmaceuticals Inc. (XERS) Announces Positive Topline Phase 2 Clinical Data of Its Investigational XeriSol-Formulated Once-Weekly Subcutaneous Levothyroxine (XP-8121)
May 29, 2024 08:08AM
May 24, 2024 08:20AM
May 24, 2024 07:49AM
May 24, 2024 07:38AM
May 24, 2024 06:53AM
May 22, 2024 04:55PM
May 21, 2024 07:01AM Citius Pharmaceuticals (CTXR) Achieves Primary and Secondary Endpoints in Phase 3 Trial of Mino-Lok Antibiotic Lock Solution
May 20, 2024 06:00AM
May 15, 2024 08:45AM
May 14, 2024 08:33AM
May 10, 2024 04:48AM
May 7, 2024 03:30PM
May 6, 2024 07:59AM
May 6, 2024 07:03AM EyePoint (EYPT) Phase 2 PAVIA Trial of DURAVYU in Non-Proliferative Diabetic Retinopathy Did Not Meet its Primary Endpoint
May 1, 2024 08:32AM
Apr 29, 2024 10:21AM
Apr 29, 2024 10:11AM
Apr 25, 2024 06:55AM
Apr 23, 2024 02:12PM
Apr 22, 2024 04:05PM
Apr 17, 2024 07:09AM Inspire Medical (INSP), ResMed (RMD) on Watch Following Report on Sleep Apnea
Apr 16, 2024 07:06AM
Apr 15, 2024 10:32AM
Apr 15, 2024 08:05AM
Apr 15, 2024 07:01AM
Apr 15, 2024 06:30AM
Apr 10, 2024 09:02AM
Apr 9, 2024 08:02AM YS Biopharma (YS) Announces Positive Interim Results of Pivotal Phase 3 Clinical Study of PIKA Rabies Vaccine
Apr 9, 2024 08:01AM
Apr 9, 2024 07:07AM
Apr 9, 2024 06:45AM
Apr 8, 2024 08:05AM
Apr 5, 2024 07:30AM
Apr 4, 2024 08:41AM
Apr 3, 2024 04:30PM Macrogenics (MGNX) Provides Phase 2 TAMARACK Study Early Interim Safety Data and Plans for Future Disclosures
Mar 28, 2024 07:30AM
Mar 27, 2024 07:12AM
Mar 27, 2024 07:07AM
Mar 26, 2024 07:35AM
Mar 26, 2024 07:12AM
Mar 26, 2024 07:09AM
Mar 26, 2024 07:03AM Moderna (MRNA) Achieves Positive Interim Results from Phase 3 Trial of Next-Generation COVID-19 Vaccine
Mar 21, 2024 07:23AM

5,528 total articles have been posted to this category.

Sign-up to StreetInsider.com Premium to see all today's market moving Hot FDA News reports.